Announcements Trials
Browse Landscape

Phase

Phase 1/2 11Phase 1 11Phase NA 7Phase EARLY_PHASE1 3Phase 3 1Phase 2/3 1Phase 2 1

Status

Unknown 3Terminated 1Suspended 1Not yet recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3

Conditions

Multiple Myeloma 26Breast Neoplasms 21Colorectal Neoplasms 17Neoplasms 15Lymphoma, B-Cell 15Prostatic Neoplasms 14Stomach Neoplasms 12Carcinoma, Hepatocellular 12Recurrence 11Lung Neoplasms 11Burkitt Lymphoma 11Solid Tumor 10Pancreatic Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Non-Small-Cell Lung 10Uterine Cervical Neoplasms 9Lymphoma, Non-Hodgkin 9Glioblastoma 9Leukemia 8Ovarian Neoplasms 7Sarcoma 6Polycystic Ovary Syndrome 6Glioma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Hematologic Neoplasms 5Head and Neck Neoplasms 5Neuroendocrine Tumors 4Lymphoma, T-Cell, Peripheral 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Leukemia, B-Cell × Clear all
NCT04439721 2021-01-06

γδT

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Phase EARLY_PHASE1 Unknown
5 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell

NCT04156178 2019-11-12

CD20-CD19 Compound CAR (cCAR) T Cells for Patients With Relapsed /Refractory B Cell Malignancies

iCell Gene Therapeutics

Phase EARLY_PHASE1 Unknown
12 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, B-Cell, Lymphoma, B-Cell

NCT04156243 2019-11-12

CD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell Malignancies

iCell Gene Therapeutics

Phase EARLY_PHASE1 Unknown
20 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡